Cargando…

Influence of Polyvinylpyrrolidone Molecular Weight and Concentration on the Precipitation Inhibition of Supersaturated Solutions of Poorly Soluble Drugs

Supersaturating drug delivery systems such as solid dispersions of a drug in a polymer are frequently used in pharmaceutical development to enable oral delivery of poorly soluble drugs. In this study, the influence of the concentration and molecular weight of polyvinylpyrrolidone (PVP) on the precip...

Descripción completa

Detalles Bibliográficos
Autores principales: Odeh, Afnan Bany, El-Sayed, Boushra, Knopp, Matthias Manne, Rades, Thomas, Blaabjerg, Lasse Ingerslev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304178/
https://www.ncbi.nlm.nih.gov/pubmed/37376048
http://dx.doi.org/10.3390/pharmaceutics15061601
_version_ 1785065445876826112
author Odeh, Afnan Bany
El-Sayed, Boushra
Knopp, Matthias Manne
Rades, Thomas
Blaabjerg, Lasse Ingerslev
author_facet Odeh, Afnan Bany
El-Sayed, Boushra
Knopp, Matthias Manne
Rades, Thomas
Blaabjerg, Lasse Ingerslev
author_sort Odeh, Afnan Bany
collection PubMed
description Supersaturating drug delivery systems such as solid dispersions of a drug in a polymer are frequently used in pharmaceutical development to enable oral delivery of poorly soluble drugs. In this study, the influence of the concentration and molecular weight of polyvinylpyrrolidone (PVP) on the precipitation inhibition of the poorly soluble drugs albendazole, ketoconazole and tadalafil is investigated to expand the understanding of the mechanism of PVP as a polymeric precipitation inhibitor. A three-level full-factorial design was used to delineate the influence of polymer concentration and viscosity of the dissolution medium on precipitation inhibition. Solutions of PVP K15, K30, K60 or K120 at concentrations of 0.1, 0.5 and 1% (w/v), as well as isoviscous solutions of PVP of increasing molecular weight, were prepared. Supersaturation of the three model drugs was induced by the use of a solvent-shift method. Precipitation of the three model drugs from supersaturated solutions in the absence and presence of polymer was investigated by the use of a solvent-shift method. Time–concentration profiles of the respective drugs in the absence and presence of polymer pre-dissolved in the dissolution medium were obtained by the use of a μDISS Profiler™ to determine the onset of nucleation and the precipitation rate. Multiple linear regression was used to evaluate the hypothesis that precipitation inhibition is influenced by the PVP concentration (i.e., the number of repeat units of the polymer) and the medium viscosity of the polymer for the three model drugs. This study showed that an increased concentration of PVP (i.e., an increased concentration of the PVP repeat units, independent of the molecular weight of the polymer) in solution increased the onset of nucleation and decreased the precipitation rate of the respective drugs during supersaturation, which can be explained by an increase in molecular interactions between the drug and polymer with increasing concentrations of polymer. In contrast, the medium viscosity had no significant influence on the onset of the nucleation and precipitation rate of the drugs, which can be explained by solution viscosity having a negligible effect on the rate of drug diffusion from bulk solution to the crystal nuclei. In conclusion, the precipitation inhibition of the respective drugs is influenced by the concentration of PVP, i.e., by molecular interactions between the drug and polymer. In contrast, the molecular mobility of the drug in solution, i.e., the medium viscosity, has no influence on the precipitation inhibition of the drugs.
format Online
Article
Text
id pubmed-10304178
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103041782023-06-29 Influence of Polyvinylpyrrolidone Molecular Weight and Concentration on the Precipitation Inhibition of Supersaturated Solutions of Poorly Soluble Drugs Odeh, Afnan Bany El-Sayed, Boushra Knopp, Matthias Manne Rades, Thomas Blaabjerg, Lasse Ingerslev Pharmaceutics Article Supersaturating drug delivery systems such as solid dispersions of a drug in a polymer are frequently used in pharmaceutical development to enable oral delivery of poorly soluble drugs. In this study, the influence of the concentration and molecular weight of polyvinylpyrrolidone (PVP) on the precipitation inhibition of the poorly soluble drugs albendazole, ketoconazole and tadalafil is investigated to expand the understanding of the mechanism of PVP as a polymeric precipitation inhibitor. A three-level full-factorial design was used to delineate the influence of polymer concentration and viscosity of the dissolution medium on precipitation inhibition. Solutions of PVP K15, K30, K60 or K120 at concentrations of 0.1, 0.5 and 1% (w/v), as well as isoviscous solutions of PVP of increasing molecular weight, were prepared. Supersaturation of the three model drugs was induced by the use of a solvent-shift method. Precipitation of the three model drugs from supersaturated solutions in the absence and presence of polymer was investigated by the use of a solvent-shift method. Time–concentration profiles of the respective drugs in the absence and presence of polymer pre-dissolved in the dissolution medium were obtained by the use of a μDISS Profiler™ to determine the onset of nucleation and the precipitation rate. Multiple linear regression was used to evaluate the hypothesis that precipitation inhibition is influenced by the PVP concentration (i.e., the number of repeat units of the polymer) and the medium viscosity of the polymer for the three model drugs. This study showed that an increased concentration of PVP (i.e., an increased concentration of the PVP repeat units, independent of the molecular weight of the polymer) in solution increased the onset of nucleation and decreased the precipitation rate of the respective drugs during supersaturation, which can be explained by an increase in molecular interactions between the drug and polymer with increasing concentrations of polymer. In contrast, the medium viscosity had no significant influence on the onset of the nucleation and precipitation rate of the drugs, which can be explained by solution viscosity having a negligible effect on the rate of drug diffusion from bulk solution to the crystal nuclei. In conclusion, the precipitation inhibition of the respective drugs is influenced by the concentration of PVP, i.e., by molecular interactions between the drug and polymer. In contrast, the molecular mobility of the drug in solution, i.e., the medium viscosity, has no influence on the precipitation inhibition of the drugs. MDPI 2023-05-26 /pmc/articles/PMC10304178/ /pubmed/37376048 http://dx.doi.org/10.3390/pharmaceutics15061601 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Odeh, Afnan Bany
El-Sayed, Boushra
Knopp, Matthias Manne
Rades, Thomas
Blaabjerg, Lasse Ingerslev
Influence of Polyvinylpyrrolidone Molecular Weight and Concentration on the Precipitation Inhibition of Supersaturated Solutions of Poorly Soluble Drugs
title Influence of Polyvinylpyrrolidone Molecular Weight and Concentration on the Precipitation Inhibition of Supersaturated Solutions of Poorly Soluble Drugs
title_full Influence of Polyvinylpyrrolidone Molecular Weight and Concentration on the Precipitation Inhibition of Supersaturated Solutions of Poorly Soluble Drugs
title_fullStr Influence of Polyvinylpyrrolidone Molecular Weight and Concentration on the Precipitation Inhibition of Supersaturated Solutions of Poorly Soluble Drugs
title_full_unstemmed Influence of Polyvinylpyrrolidone Molecular Weight and Concentration on the Precipitation Inhibition of Supersaturated Solutions of Poorly Soluble Drugs
title_short Influence of Polyvinylpyrrolidone Molecular Weight and Concentration on the Precipitation Inhibition of Supersaturated Solutions of Poorly Soluble Drugs
title_sort influence of polyvinylpyrrolidone molecular weight and concentration on the precipitation inhibition of supersaturated solutions of poorly soluble drugs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304178/
https://www.ncbi.nlm.nih.gov/pubmed/37376048
http://dx.doi.org/10.3390/pharmaceutics15061601
work_keys_str_mv AT odehafnanbany influenceofpolyvinylpyrrolidonemolecularweightandconcentrationontheprecipitationinhibitionofsupersaturatedsolutionsofpoorlysolubledrugs
AT elsayedboushra influenceofpolyvinylpyrrolidonemolecularweightandconcentrationontheprecipitationinhibitionofsupersaturatedsolutionsofpoorlysolubledrugs
AT knoppmatthiasmanne influenceofpolyvinylpyrrolidonemolecularweightandconcentrationontheprecipitationinhibitionofsupersaturatedsolutionsofpoorlysolubledrugs
AT radesthomas influenceofpolyvinylpyrrolidonemolecularweightandconcentrationontheprecipitationinhibitionofsupersaturatedsolutionsofpoorlysolubledrugs
AT blaabjerglasseingerslev influenceofpolyvinylpyrrolidonemolecularweightandconcentrationontheprecipitationinhibitionofsupersaturatedsolutionsofpoorlysolubledrugs